| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/15/1998 | US5808097 Proline derivatives |
| 09/15/1998 | US5808096 Process for preparing active carbonates of polyalkylene oxides for modification of polypeptides |
| 09/15/1998 | US5808037 Oligomers which inhibit expression of collagen genes |
| 09/15/1998 | US5808033 Family of anti-carcinoembryonic antigen chimeric antibodies |
| 09/15/1998 | US5808030 Polypeptide |
| 09/15/1998 | US5808029 Genetic engineering |
| 09/15/1998 | US5808028 Molecular clone of a P58 receptor protein and uses thereof |
| 09/15/1998 | US5808027 N-2 substituted purines in oligonucleotides |
| 09/15/1998 | US5808025 Polypeptide |
| 09/15/1998 | US5808008 Method of producing human pluripotent hematopoietic colony stimulating factor |
| 09/15/1998 | US5808007 Treating cell proliferative or immunologic disorders |
| 09/15/1998 | US5808006 Refolding of polypeptides like recombinant insulin-like growth factor IGF-I |
| 09/15/1998 | US5808005 Medical diagnosis; vaccines |
| 09/15/1998 | US5808004 Fragments of a lymphocyte adhesion receptor for high endothelium, CD44 |
| 09/15/1998 | US5808002 Stem cell factor receptor-(c-kit)-specific monoclonal antibody A3C6E2 |
| 09/15/1998 | US5807996 Fused polypeptides comprising interleukin-4 polypeptide fragments |
| 09/15/1998 | US5807991 Human interleukin-5 receptor |
| 09/15/1998 | US5807989 Genetic and nervous system disorders; purified polypeptide |
| 09/15/1998 | US5807988 Isolation, characterization, and use of the human and subunit of the high affinity receptor for immunoglobulin E |
| 09/15/1998 | US5807986 Genetic engineering |
| 09/15/1998 | US5807985 Oligopeptide compounds containing D-2-alkyltryptophan capable of promoting the release of growth hormone |
| 09/15/1998 | US5807984 Controlling diseases; pentapeptides |
| 09/15/1998 | US5807983 Human gonadotropin releasing hormone |
| 09/15/1998 | US5807980 Bovine pancreatic trypsin inhibitor derived inhibitors of factor VIIa-tissue factor complex |
| 09/15/1998 | US5807978 Polypeptide with hydrophilic and hydrophobic regions; cancer diagnosis |
| 09/15/1998 | US5807891 Antiviral ethers of aspartate protease substrate isosteres |
| 09/15/1998 | US5807890 Antiodor, antimicrobial and preservative compositions and methods of using same |
| 09/15/1998 | US5807884 Treatment for atherosclerosis and other cardiovascular and inflammatory diseases |
| 09/15/1998 | US5807875 Obesity therapy |
| 09/15/1998 | US5807840 Administering product r |
| 09/15/1998 | US5807839 Method for stimulating red blood cell production |
| 09/15/1998 | US5807836 Interferon regulatory factors 1 and 2 in the diagnosis of tumorigenicity |
| 09/15/1998 | US5807831 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules |
| 09/15/1998 | US5807830 Method for treatment of purulent inflammatory diseases |
| 09/15/1998 | US5807829 Serine protease inhibitor--tripeptoid analogs |
| 09/15/1998 | US5807828 Platelet aggregation inhibitors |
| 09/15/1998 | US5807827 Narcotic analgesic potentiation, narcotic withdrawal |
| 09/15/1998 | US5807826 Semaphorin gene family |
| 09/15/1998 | US5807825 Platelet aggregation inhibitors |
| 09/15/1998 | US5807824 C5A receptor antagonists having substantially no agonist activity |
| 09/15/1998 | US5807823 Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis |
| 09/15/1998 | US5807822 Insulin-like growth factor II as a pharmaceutical agent in the treatment of osteopenias |
| 09/15/1998 | US5807821 Treating cancer and post-surgery pain; side effect reduction, non-habit forming |
| 09/15/1998 | US5807820 Cyclosporin compositions for topical application |
| 09/15/1998 | US5807819 Using an oligopeptide |
| 09/15/1998 | US5807818 Therapeutic uses of bactericidal/permeability increasing protein (BPI) protein products |
| 09/15/1998 | US5807757 Controlling particle size distribution |
| 09/15/1998 | US5807746 Administering signal peptide complex; antisense therapy, gene transfer |
| 09/15/1998 | US5807744 Incubation; separation of bone marrow and tumor cells |
| 09/15/1998 | US5807743 Nucleic acid |
| 09/15/1998 | US5807741 Neutralizing monoclonal antibody against botulinum neurotoxin serotype F |
| 09/15/1998 | US5807738 Human fetoprotein |
| 09/15/1998 | US5807734 Polypeptide |
| 09/15/1998 | US5807732 GDP-L-fucose: β-D-galactoside 2-α-L-fucosyltransferases, DNA sequences encoding the same, method for producing the same and a method of genotyping a person |
| 09/15/1998 | US5807731 Antitumor |
| 09/15/1998 | US5807726 Nucleic acids encoding dog gastric lipase and their use for the production of polypeptides |
| 09/15/1998 | US5807723 Homologously recombinant slow growing mycobacteria and uses therefor |
| 09/15/1998 | US5807715 Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin |
| 09/15/1998 | US5807714 Method of production of antigen-specific glycosylation inhibiting factor |
| 09/15/1998 | US5807713 Transforming growth factor |
| 09/15/1998 | US5807712 Genetic engineered protein |
| 09/15/1998 | US5807709 Secreted proteins and polynucleotides encoding them |
| 09/15/1998 | US5807708 Conservin nucleic acid molecules and compositions |
| 09/15/1998 | US5807706 Genetic engineering |
| 09/15/1998 | US5807705 Antigen recognized by patients with antibody associated paraneoplastic sensory neuronopathy, DNA encoding same and uses thereof |
| 09/15/1998 | US5807703 Secreted proteins and polynucleotides encoding them |
| 09/15/1998 | US5807702 Genetic engineering |
| 09/15/1998 | US5807698 Human cyclin E |
| 09/15/1998 | US5807692 P21WAF1 derivatives and diagnostic methods |
| 09/15/1998 | US5807691 Polypeptides having serotonin receptor activity (5HT5A), nucleic acids coding for these polypeptides and uses thereof |
| 09/15/1998 | US5807688 Catalytic antibodies for carbamate activation by a non-spontaneous reaction mechanism |
| 09/15/1998 | US5807581 Collagen-based injectable drug delivery system and its use |
| 09/15/1998 | US5807559 Compositions for generating T cell immunity against carbohydrate structures |
| 09/15/1998 | US5807557 Vaccine |
| 09/15/1998 | US5807556 Methods of preventing degeneration of myoplasties |
| 09/15/1998 | US5807554 Osteoporosis; skin and sleep disorders |
| 09/15/1998 | US5807552 Compositions for conferring immunogenicity to a substance and uses thereof |
| 09/15/1998 | US5807551 Method to provide artificial passive immunity in birds |
| 09/15/1998 | US5807550 Antibodies specifically recognizing somatotropin binding proteins |
| 09/15/1998 | US5807549 Lymphocyte chemoattractant factor and uses thereof |
| 09/15/1998 | US5807548 Method of treating cancer using a chimera antibody |
| 09/15/1998 | US5807537 Medical diagnosis |
| 09/15/1998 | US5807534 In vivo binding pair pretargeting |
| 09/15/1998 | US5807315 Methods and devices for the delivery of monomeric proteins |
| 09/15/1998 | CA2146414C Treatment of h. pylori infections |
| 09/15/1998 | CA2106080C Trk tyrosine kinase receptor is the physiological receptor for nerve growth factor |
| 09/14/1998 | CA2221830A1 Tumor necrosis factor related receptor, tr6 |
| 09/13/1998 | CA2199989A1 Expression of a foamy virus envelope protein |
| 09/12/1998 | CA2219964A1 Polypeptide capable of binding interleukin-18 and uses therof |
| 09/11/1998 | WO1998039659A1 Screening and treatment using complement regulator or receptor proteins |
| 09/11/1998 | WO1998039486A1 Methods and compositions for the treatment of injury to the central nervous system |
| 09/11/1998 | WO1998039469A1 Isolation of tissue specific peptide ligands and their use for targeting pharmaceuticals to organs |
| 09/11/1998 | WO1998039467A2 Adenovirus vectors specific for cells expressing carcinoembryonic antigen and methods of use thereof |
| 09/11/1998 | WO1998039465A2 Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof |
| 09/11/1998 | WO1998039449A1 COMPOSITIONS AND USE OF M-CSF-alpha |
| 09/11/1998 | WO1998039448A9 186 human secreted proteins |
| 09/11/1998 | WO1998039448A2 186 human secreted proteins |
| 09/11/1998 | WO1998039446A2 70 human secreted proteins |
| 09/11/1998 | WO1998039445A1 Human tubby homolog |
| 09/11/1998 | WO1998039444A1 Protein kinase c inhibitor-like protein (ipkc-2) |